argenx SE (ARGX)
802.70
-9.60
(-1.18%)
USD |
NASDAQ |
Oct 13, 16:00
802.54
-0.16
(-0.02%)
After-Hours: 20:00
argenx Free Cash Flow : 1.090B for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.090B |
| December 31, 2025 | 734.26M |
| June 30, 2025 | 447.35M |
| December 31, 2024 | -39.32M |
| June 30, 2024 | -211.22M |
| December 31, 2023 | -371.93M |
| June 30, 2023 | -723.42M |
| December 31, 2022 | -955.16M |
| June 30, 2022 | -868.07M |
| December 31, 2021 | -723.73M |
| June 30, 2021 | -598.85M |
| Date | Value |
|---|---|
| December 31, 2020 | -398.65M |
| June 30, 2020 | -255.80M |
| December 31, 2019 | 109.07M |
| June 30, 2019 | 189.72M |
| December 31, 2018 | -61.16M |
| June 30, 2018 | -58.03M |
| December 31, 2017 | -42.95M |
| June 30, 2017 | -30.70M |
| December 31, 2016 | 10.76M |
| June 30, 2016 | 15.00M |
| December 31, 2015 | -15.51M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Autolus Therapeutics Plc | -240.12M |
| Cellectis SA | -45.36M |
| Akari Therapeutics Plc | -10.74M |
| Forte Biosciences, Inc. | -72.03M |
| Halozyme Therapeutics, Inc. | 806.22M |
Free Cash Flow Related Metrics
| Free Cash Flow Yield | 2.08% |